Cargando…
Emerging Therapies in CLL in the Era of Precision Medicine
SIMPLE SUMMARY: Despite being a slow-proliferating disease, chronic lymphocytic leukemia (CLL) is an incurable and frequently reoccurring adult leukemia. Although large-scale genome-wide next-generation sequencing studies have provided insights into CLL’s transcriptome and mutational landscape, the...
Autores principales: | Iyer, Prajish, Wang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000606/ https://www.ncbi.nlm.nih.gov/pubmed/36900373 http://dx.doi.org/10.3390/cancers15051583 |
Ejemplares similares
-
Proteomics and Drug Repurposing in CLL towards Precision Medicine
por: Mavridou, Dimitra, et al.
Publicado: (2021) -
Targeting CLL-1 for acute myeloid leukemia therapy
por: Ma, Hongbing, et al.
Publicado: (2019) -
Proton beam therapy for cancer in the era of precision medicine
por: Hu, Man, et al.
Publicado: (2018) -
Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019) -
Validating genomic tools for precision medicine in CLL: ERIC leads the way
por: Wiestner, Adrian
Publicado: (2021)